Daniel Wilcock

Company: RedX Pharma

Job title: Principal Translational Scientist

Seminars:

The Big Debate: Pan-Antifibrotics, Fact or Fiction? Dissecting Mechanisms & Organ Specificity & Strategies for Cross-Tissue Success 2:00 pm - 4:00 pm

As interest grows in developing antifibrotics with cross-indication potential, this workshop critically examines whether a true “pan-antifibrotic” is biologically and clinically feasible. Through real-world data, mechanistic comparisons, and forward-looking trial design strategies, we’ll explore what it would take to deliver a truly universal fibrosismodifying therapy. This workshop will gather experts to discuss: Reviewing trials of…Read more

day: Pre-Conference Day